OGT
The company believes cytogeneticists will adopt its panel to get high-quality SNV and CNV data in a single assay.
Sysmex to Acquire Oxford Gene Technology
The acquisition allows Sysmex to enter the cytogenetics market and strengthens its technology base in molecular genetics, while expanding its life science business.
Oxford Gene Technology Bets on Design, Flexibility to Woo Clinical Labs With New NGS Cancer Panel
Premium
The British molecular genetics company recently announced a menu update for its SureSeq myPanel NGS Custom Cancer Panel offering.
Oxford Gene Technology FY16 Revenues Up 15 Percent
The revenue growth comes amid increased demand for the company's molecular genetics products.
In Brexit Britain, Genomics Community Anxious About Future EU Funding, Collaboration, Innovation
Premium
Interviews with leading UK scientists revealed apprehension about losing access to European funding, limitations on freedom of movement, and an exodus of biotechs to the EU.
Oct 6, 2015
OGT FISH Kit for Bladder Cancer Gets CE-IVD Mark
Apr 8, 2015
Jul 15, 2014
Mar 28, 2014
Mar 25, 2014
Mar 4, 2014